Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Insights, Forecast to 2029

Published: August 2023

No. of Pages: 93

Price:

Single User License: US $ 4900

Corporate User License: US $ 9800

Report Description
Table of Contents

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
Market Analysis and Insights: Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market

The global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment include Stryker, Balt, TERUMO, MicroPort and Acandis, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Stryker, Balt, TERUMO, MicroPort and Acandis, etc.

By Company
- Stryker
- Balt
- TERUMO
- MicroPort
- Acandis

Segment by Type
- Stent
- PTA Balloon

Segment by Application
- Hospital
- Clinic
- Other

By Region
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East, Africa, and Latin America
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment companies competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market by Application
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Perspective (2018-2029)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Growth Trends by Region
2.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Historic Market Size by Region (2018-2023)
2.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Region (2024-2029)
2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Dynamics
2.3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Industry Trends
2.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Drivers
2.3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Challenges
2.3.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment by Players
3.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Players (2018-2023)
3.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Players (2018-2023)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Concentration Ratio
3.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue in 2022
3.5 Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Head office and Area Served
3.6 Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, Product and Application
3.7 Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Breakdown Data by Type
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Historic Market Size by Type (2018-2023)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Type (2024-2029)
5 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Breakdown Data by Application
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Historic Market Size by Application (2018-2023)
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2018-2029)
6.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
6.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023)
6.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029)
6.2.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
6.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
6.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023)
6.3.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029)
6.3.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
6.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country
6.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2018-2023)
6.4.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2018-2029)
7.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
7.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023)
7.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029)
7.2.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
7.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
7.3.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023)
7.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029)
7.3.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
7.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country
7.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2018-2023)
7.4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2018-2029)
8.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
8.2.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023)
8.2.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029)
8.2.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
8.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
8.3.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023)
8.3.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029)
8.3.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2018-2029)
9.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
9.2.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023)
9.2.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029)
9.2.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
9.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
9.3.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023)
9.3.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029)
9.3.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
9.4 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region
9.4.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2018-2023)
9.4.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.1.4 Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
11.1.5 Stryker Recent Developments
11.2 Balt
11.2.1 Balt Company Details
11.2.2 Balt Business Overview
11.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.2.4 Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
11.2.5 Balt Recent Developments
11.3 TERUMO
11.3.1 TERUMO Company Details
11.3.2 TERUMO Business Overview
11.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.3.4 TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
11.3.5 TERUMO Recent Developments
11.4 MicroPort
11.4.1 MicroPort Company Details
11.4.2 MicroPort Business Overview
11.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.4.4 MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
11.4.5 MicroPort Recent Developments
11.5 Acandis
11.5.1 Acandis Company Details
11.5.2 Acandis Business Overview
11.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Introduction
11.5.4 Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
11.5.5 Acandis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Stent
Table 3. Key Players of PTA Balloon
Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Region (2018-2023)
Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Region (2024-2029)
Table 10. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Trends
Table 11. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Drivers
Table 12. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Challenges
Table 13. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Restraints
Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment as of 2022)
Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, Headquarters and Area Served
Table 20. Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, Product and Application
Table 21. Global Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Application (2018-2023)
Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Application (2024-2029)
Table 31. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. Stryker Company Details
Table 64. Stryker Business Overview
Table 65. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 66. Stryker Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023) & (US$ Million)
Table 67. Stryker Recent Developments
Table 68. Balt Company Details
Table 69. Balt Business Overview
Table 70. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 71. Balt Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023) & (US$ Million)
Table 72. Balt Recent Developments
Table 73. TERUMO Company Details
Table 74. TERUMO Business Overview
Table 75. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 76. TERUMO Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023) & (US$ Million)
Table 77. TERUMO Recent Developments
Table 78. MicroPort Company Details
Table 79. MicroPort Business Overview
Table 80. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 81. MicroPort Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023) & (US$ Million)
Table 82. MicroPort Recent Developments
Table 83. Acandis Company Details
Table 84. Acandis Business Overview
Table 85. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product
Table 86. Acandis Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023) & (US$ Million)
Table 87. Acandis Recent Developments
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type: 2022 VS 2029
Figure 3. Stent Features
Figure 4. PTA Balloon Features
Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Report Years Considered
Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Players in 2022
Figure 15. Global Top ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue in 2022
Figure 17. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
Figure 19. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
Figure 20. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Country (2018-2029)
Figure 21. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
Figure 25. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
Figure 26. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Country (2018-2029)
Figure 27. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
Figure 35. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
Figure 36. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
Figure 38. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
Figure 39. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Region (2018-2029)
Figure 40. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share by Country (2018-2029)
Figure 50. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Stryker Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
Figure 57. Balt Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
Figure 58. TERUMO Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
Figure 59. MicroPort Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
Figure 60. Acandis Revenue Growth Rate in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group2559516

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2023 Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2022 - Market Size, Current Insights and Development Trends Intracranial atherosclerotic disease (ICAD) is the most common cause of stroke worldwide. It is the progressive narrowing of the cerebral arteries within the skull (intracranial). Strokes may be caused either by clots or by bleeding (hemorrhage) that...
2023-2031 Report on Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Player, Region, Type, Application and Sales Channel This report studies the ICAD (Intracranial Atherosclerotic Disease) Pathology market, covering market size for segment by type (ICAD Stent, PTA Balloon, etc.), by application (Hospitals, Clinics, etc.), by sales channel (Direct Channel, Distribution ...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth 2023-2029 Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Insights: Impact of COVID-19 and Future Expectations to 2028 Intracranial atherosclerotic disease (ICAD) is the most common cause of stroke worldwide. It is the progressive narrowing of the cerebral arteries within the skull (intracranial). Strokes may be caused either by clots or by bleeding (hemorrhage) that...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Research Report 2023 This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market with multiple angle...
Global ICAD (Intracranial Atherosclerotic Disease Pathology) Market Insights: Impact of COVID-19 and Future Expectations to 2028 The ICAD (Intracranial Atherosclerotic Disease Pathology) market revenue was 185.41 Million USD in 2022, and will reach 343.21 Million USD in 2028, with a CAGR of 10.81% during 2022-2028. This report elaborates the market size, market ...
ICAD (Intracranial Atherosclerotic Disease) Pathology Market, Global Outlook and Forecast 2023-2029 Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of...
Global ICAD (Intracranial Atherosclerotic Disease Pathology) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028 Market Overview of Global ICAD (Intracranial Atherosclerotic Disease Pathology) market: According to our latest research, the global ICAD (Intracranial Atherosclerotic Disease Pathology) market looks promising in the next 5 years. As of 2022, t...
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook 2022 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

We're Here To Help You

Request for Sample of this report